Hypovitaminosis D and iron deficiency Nutritional, Metabolic, Endocrine Hypovitaminosis D and iron deficiency
Conditions
Interventions
The study is cross-sectional study. Participants have the variables of interested measured. This includes measurements for body iron content (calculated using Cook's formula) and 25hydroxivitamin D le
Sponsors
Instituto De Medicina Integral Professor Fernando Figueira
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women older than 18 years old 2. Who did not have chronic diseases 3. In whom the results of 25-hydroxyvitamin D (25OHD) 4. Soluble transferrin receptor (sTfR) 5. Ferritin levels available 6. Chronic diseases as defined as the following a self-report of cancer, heart failure, pulmonary emphysema, chronic bronchitis, gastric or intestinal diseases; changes in laboratory markers of liver disease (aspartate aminotransferase greater than 121 U/L, alanine aminotransferase greater than 128 U/L and total bilirubin greater than 2.1 mg/dL) or renal disease (creatinine greater than 1.5 mg/dL); and the presence of a HIV-positive serology.
Exclusion criteria
Exclusion criteria: 1. Women who reported undergoing iron supplementation in the last 3 months 2. Who had a positive pregnancy test or changes in the markers of malnutrition (albumin 5.0 mg/dL) or iron overload (transferrin saturation > 45%)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vitamin D levels in correlation with body iron stores (BIS) are measured using patient data and a predictive model. | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures. | — |
Countries
United States of America
Contacts
Public ContactDaniely Barbosa
Outcome results
None listed